ClinVar Miner

Submissions for variant NM_001130987.2(DYSF):c.6174G>A (p.Arg2058=)

gnomAD frequency: 0.00044  dbSNP: rs143762717
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 13
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000724811 SCV000231347 uncertain significance not provided 2017-08-22 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000352290 SCV000431852 uncertain significance Limb-girdle muscular dystrophy, recessive 2016-06-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000401726 SCV000431853 uncertain significance Miyoshi myopathy 2016-06-14 criteria provided, single submitter clinical testing
Invitae RCV001080306 SCV000649737 likely benign Qualitative or quantitative defects of dysferlin 2024-01-19 criteria provided, single submitter clinical testing
GeneDx RCV000724811 SCV000715709 likely benign not provided 2020-10-23 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000724811 SCV001152344 uncertain significance not provided 2018-12-01 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001080306 SCV001298127 uncertain significance Qualitative or quantitative defects of dysferlin 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Kids Neuroscience Centre, Sydney Children's Hospitals Network RCV001276873 SCV001571524 uncertain significance Autosomal recessive limb-girdle muscular dystrophy type 2B criteria provided, single submitter provider interpretation No evidence that the c.6057G>A variant affects the splicing of DYSF mRNA. This variant is synonymous p.(Arg2019=) and is not predicted to impact the DYSF protein.
Athena Diagnostics RCV000724811 SCV002770748 uncertain significance not provided 2021-10-29 criteria provided, single submitter clinical testing
Revvity Omics, Revvity RCV000724811 SCV003831357 likely benign not provided 2023-07-12 criteria provided, single submitter clinical testing
Ambry Genetics RCV003243003 SCV003950191 likely benign Inborn genetic diseases 2023-05-23 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
PreventionGenetics, part of Exact Sciences RCV003977471 SCV004798796 likely benign DYSF-related disorder 2020-09-14 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Natera, Inc. RCV001276873 SCV001463488 likely benign Autosomal recessive limb-girdle muscular dystrophy type 2B 2020-06-13 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.